Penumbra Net Worth 2014-2022 | PEN

Interactive chart of historical net worth (market cap) for Penumbra (PEN) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Penumbra net worth as of December 07, 2022 is $8.36B.
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $8.355B $0.748B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $218.900B 22.89
Edwards Lifesciences (EW) United States $44.873B 30.89
Alcon (ALC) Switzerland $33.262B 28.64
STERIS (STE) Ireland $18.523B 23.05
Teleflex (TFX) United States $11.273B 18.29
Fresenius Medical Care AG KGaA (FMS) Germany $9.266B 9.30
Globus Medical (GMED) United States $6.995B 35.56
Integer Holdings (ITGR) United States $2.380B 19.11
Glaukos (GKOS) United States $2.160B 0.00
Paragon 28 (FNA) United States $1.535B 0.00
Nevro (NVRO) United States $1.482B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.208B 17.20
Artivion (AORT) United States $0.511B 0.00